- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 10: The Important Distinction Between Diagnostic, Screening Tests
There is an important distinction between diagnostic and screening tests, and they have different issues in regards to decision making-although the person making treatment decisions should ultimately be guiding the ship, according to Bryan Loy, MD, MBA.
There is an important distinction between diagnostic and screening tests, and they have different issues in regards to decision making—although the person making treatment decisions should ultimately be guiding the ship, according to Bryan Loy, MD, MBA.
He added that he’s always surprised to learn the lack of medical history that is taken, for example, in conjunction with a BRCA1 or BRCA2 test.
“It feels like we’ve still got a long way to go in creating some accountability and a measurement system and education system to get people ordering them thoughtfully,” Dr Loy said.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
